Literature DB >> 11602585

Partial phosphorylation of the N-formyl peptide receptor inhibits G protein association independent of arrestin binding.

T A Bennett1, T D Foutz, V V Gurevich, L A Sklar, E R Prossnitz.   

Abstract

It is now well accepted that G protein-coupled receptors activated by agonist binding become targets for phosphorylation, leading to desensitization of the receptor. Using a series of phosphorylation deficient mutants of the N-formyl peptide receptor (FPR), we have explored the role of phosphorylation on the ability of the receptor to interact with G proteins and arrestins. Using a fluorometric assay in conjunction with solubilized receptors, we demonstrate that phosphorylation of the wild type FPR lowers its affinity for G protein, whereas mutant receptors lacking four potential phosphorylation sites retain their ability to couple to G protein. Phosphorylated mutant receptors lacking only two potential phosphorylation sites are again unable to couple to G protein. Furthermore, whereas stimulated wild type FPR in whole cells colocalizes with arrestin-2, and the solubilized, phosphorylated FPR binds arrestin-2, the stimulated receptors lacking four potential phosphorylation sites display no interaction with arrestin-2. However, the mutant receptors lacking only two potential phosphorylation sites are restored in their ability to bind and colocalize with arrestin-2. Thus, there is a submaximal threshold of FPR phosphorylation that simultaneously results in an inhibition of G protein binding and an induction of arrestin binding. These results are the first to demonstrate that less than maximal levels of receptor phosphorylation can block G protein binding, independent of arrestin binding. We therefore propose that phosphorylation alone may be sufficient to desensitize the FPR in vivo, raising the possibility that for certain G protein-coupled receptors, desensitization may not be the primary function of arrestin.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11602585     DOI: 10.1074/jbc.M106414200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Formyl peptide receptor-mediated ERK1/2 activation occurs through G(i) and is not dependent on beta-arrestin1/2.

Authors:  Jeannie M Gripentrog; Heini M Miettinen
Journal:  Cell Signal       Date:  2007-11-09       Impact factor: 4.315

2.  Actin dynamics rapidly reset chemoattractant receptor sensitivity following adaptation in neutrophils.

Authors:  Sheel N Dandekar; Jason S Park; Grace E Peng; James J Onuffer; Wendell A Lim; Orion D Weiner
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-09-23       Impact factor: 6.237

Review 3.  Twenty years of the G protein-coupled estrogen receptor GPER: Historical and personal perspectives.

Authors:  Matthias Barton; Edward J Filardo; Stephen J Lolait; Peter Thomas; Marcello Maggiolini; Eric R Prossnitz
Journal:  J Steroid Biochem Mol Biol       Date:  2017-03-25       Impact factor: 4.292

4.  N-formyl peptide receptor 3 (FPR3) departs from the homologous FPR2/ALX receptor with regard to the major processes governing chemoattractant receptor regulation, expression at the cell surface, and phosphorylation.

Authors:  Marie-Josèphe Rabiet; Laurence Macari; Claes Dahlgren; François Boulay
Journal:  J Biol Chem       Date:  2011-05-04       Impact factor: 5.157

5.  Deletion of the COOH-terminal domain of CXC chemokine receptor 4 leads to the down-regulation of cell-to-cell contact, enhanced motility and proliferation in breast carcinoma cells.

Authors:  Yukiko Ueda; Nicole F Neel; Evemie Schutyser; Dayanidhi Raman; Ann Richmond
Journal:  Cancer Res       Date:  2006-06-01       Impact factor: 12.701

Review 6.  International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family.

Authors:  Richard D Ye; François Boulay; Ji Ming Wang; Claes Dahlgren; Craig Gerard; Marc Parmentier; Charles N Serhan; Philip M Murphy
Journal:  Pharmacol Rev       Date:  2009-06-04       Impact factor: 25.468

7.  Arrestin binds to different phosphorylated regions of the thyrotropin-releasing hormone receptor with distinct functional consequences.

Authors:  Brian W Jones; Patricia M Hinkle
Journal:  Mol Pharmacol       Date:  2008-04-15       Impact factor: 4.436

8.  Arrestin-3 scaffolding of the JNK3 cascade suggests a mechanism for signal amplification.

Authors:  Nicole A Perry; Tamer S Kaoud; Oscar O Ortega; Ali I Kaya; David J Marcus; John M Pleinis; Sandra Berndt; Qiuyan Chen; Xuanzhi Zhan; Kevin N Dalby; Carlos F Lopez; T M Iverson; Vsevolod V Gurevich
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-27       Impact factor: 11.205

9.  The two neutrophil members of the formylpeptide receptor family activate the NADPH-oxidase through signals that differ in sensitivity to a gelsolin derived phosphoinositide-binding peptide.

Authors:  Huamei Fu; Lena Björkman; Paul Janmey; Anna Karlsson; Jennie Karlsson; Charlotta Movitz; Claes Dahlgren
Journal:  BMC Cell Biol       Date:  2004-12-29       Impact factor: 4.241

10.  Identification of a novel recycling sequence in the C-tail of FPR2/ALX receptor: association with cell protection from apoptosis.

Authors:  Dawn Thompson; Simon McArthur; James N Hislop; Roderick J Flower; Mauro Perretti
Journal:  J Biol Chem       Date:  2014-10-17       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.